ID   MK10_HUMAN              Reviewed;         464 AA.
AC   P53779; A6NFS3; Q15707; Q49AP1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-NOV-2010, entry version 123.
DE   RecName: Full=Mitogen-activated protein kinase 10;
DE            Short=MAP kinase 10;
DE            Short=MAPK 10;
DE            EC=2.7.11.24;
DE   AltName: Full=MAP kinase p49 3F12;
DE   AltName: Full=Stress-activated protein kinase JNK3;
DE   AltName: Full=c-Jun N-terminal kinase 3;
GN   Name=MAPK10; Synonyms=JNK3, JNK3A, PRKM10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1).
RC   TISSUE=Hippocampus;
RX   MEDLINE=95127233; PubMed=7826642; DOI=10.1016/0896-6273(95)90241-4;
RA   Mohit A.A., Martin J.H., Miller C.A.;
RT   "p493F12 kinase: a novel MAP kinase expressed in a subset of neurons
RT   in the human nervous system.";
RL   Neuron 14:67-78(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1 AND ALPHA-2).
RC   TISSUE=Brain;
RX   MEDLINE=96256293; PubMed=8654373;
RA   Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K.,
RA   Derijard B., Davis R.J.;
RT   "Selective interaction of JNK protein kinase isoforms with
RT   transcription factors.";
RL   EMBO J. 15:2760-2770(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, REGULATION BY MAP2K4 AND MAP2K7,
RP   PHOSPHORYLATION AT THR-221 AND TYR-223, COFACTOR, AND MASS
RP   SPECTROMETRY.
RX   MEDLINE=20181688; PubMed=10715136; DOI=10.1021/bi992410+;
RA   Lisnock J., Griffin P., Calaycay J., Frantz B., Parsons J.,
RA   O'Keefe S.J., LoGrasso P.;
RT   "Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic
RT   characterization of in vitro phosphorylated JNK3 alpha 1.";
RL   Biochemistry 39:3141-3148(2000).
RN   [7]
RP   INTERACTION WITH SPAG9.
RX   PubMed=15693750; DOI=10.1042/BJ20041577;
RA   Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S.,
RA   Herr J.C., Okumura K., Hasegawa A., Koyama K., Suri A.;
RT   "Characterization of a novel human sperm-associated antigen 9 (SPAG9)
RT   having structural homology with c-Jun N-terminal kinase-interacting
RT   protein.";
RL   Biochem. J. 389:73-82(2005).
RN   [8]
RP   CHROMOSOMAL REARRANGEMENT, AND INVOLVEMENT IN EPILEPTIC ENCEPHALOPATHY
RP   LENNOX-GASTAUT TYPE.
RX   PubMed=16249883; DOI=10.1007/s00439-005-0084-y;
RA   Shoichet S.A., Duprez L., Hagens O., Waetzig V., Menzel C.,
RA   Herdegen T., Schweiger S., Dan B., Vamos E., Ropers H.-H.,
RA   Kalscheuer V.M.;
RT   "Truncation of the CNS-expressed JNK3 in a patient with a severe
RT   developmental epileptic encephalopathy.";
RL   Hum. Genet. 118:559-567(2006).
RN   [9]
RP   INTERACTION WITH HDAC9, AND ENZYME REGULATION.
RX   PubMed=16611996; DOI=10.1128/MCB.26.9.3550-3564.2006;
RA   Morrison B.E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R.,
RA   Olson E.N., D'Mello S.R.;
RT   "Neuroprotection by histone deacetylase-related protein.";
RL   Mol. Cell. Biol. 26:3550-3564(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-223, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [11]
RP   INTERACTION WITH ARRB2.
RX   PubMed=18435604; DOI=10.1042/BJ20080685;
RA   Xu T.-R., Baillie G.S., Bhari N., Houslay T.M., Pitt A.M., Adams D.R.,
RA   Kolch W., Houslay M.D., Milligan G.;
RT   "Mutations of beta-arrestin 2 that limit self-association also
RT   interfere with interactions with the beta2-adrenoceptor and the ERK1/2
RT   MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2
RT   MAPKs.";
RL   Biochem. J. 413:51-60(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415 AND SER-417, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 40-402.
RX   MEDLINE=98416694; PubMed=9739089; DOI=10.1016/S0969-2126(98)00100-2;
RA   Xie X., Gu Y., Fox T., Coll J.T., Fleming M.A., Markland W.,
RA   Caron P.R., Wilson K.P., Su M.S.-S.;
RT   "Crystal structure of JNK3: a kinase implicated in neuronal
RT   apoptosis.";
RL   Structure 6:983-991(1998).
CC   -!- FUNCTION: Responds to activation by environmental stress and pro-
CC       inflammatory cytokines by phosphorylating a number of
CC       transcription factors, primarily components of AP-1 such as c-Jun
CC       and ATF2 and thus regulates AP-1 transcriptional activity.
CC       Required for stress-induced neuronal apoptosis and the
CC       pathogenesis of glutamate excitotoxicity (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by two dual specificity kinases, MAP2K4 and
CC       MAP2K7. MAP2K7 phosphorylates MAPK10 on Thr-221 causing a
CC       conformational change and a large increase in Vmax. MAP2K4 then
CC       phosphorylates Tyr-223 resulting in a further increase in Vmax.
CC       Inhibited by dual specificity phosphatases, such as DUSP1.
CC       Inhibited by HDAC9.
CC   -!- SUBUNIT: Interacts with MAPKBP1 (By similarity). Binds to at least
CC       four scaffolding proteins, MAPK8IP1/JIP-1, MAPK8IP2/JIP-2,
CC       MAPK8IP3/JIP-3/JSAP1 and SPAG9/MAPK8IP4/JIP-4. These proteins also
CC       bind other components of the JNK signaling pathway. Interacts with
CC       HDAC9. Interacts with ARRB2; the interaction enhances MAPK10
CC       activation by MAP3K5.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=1; IntAct=EBI-713543, EBI-743313;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=A similar low level of binding to substrates is observed
CC         for isoform alpha-1 and isoform alpha-2. However, there is no
CC         correlation between binding and phosphorylation, which is
CC         achieved about at the same efficiency by all isoforms;
CC       Name=Alpha-2;
CC         IsoId=P53779-1; Sequence=Displayed;
CC       Name=Alpha-1;
CC         IsoId=P53779-2; Sequence=VSP_004839;
CC   -!- TISSUE SPECIFICITY: Specific to a subset of neurons in the nervous
CC       system. Present in the hippocampus and areas, cerebellum,
CC       striatum, brain stem, and weakly in the spinal cord. Very weak
CC       expression in testis and kidney.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-221 and Tyr-223, which activates
CC       the enzyme. Weakly autophosphorylated on threonine and tyrosine
CC       residues in vitro.
CC   -!- MASS SPECTROMETRY: Mass=44070; Method=Electrospray; Range=1-464;
CC       Source=PubMed:10715136;
CC   -!- DISEASE: Defects in MAPK10 are a cause of epileptic encephalopathy
CC       Lennox-Gastaut type (EELG) [MIM:606369]. Epileptic
CC       encephalopathies of the Lennox-Gastaut group are childhood
CC       epileptic disorders characterized by severe psychomotor delay and
CC       seizures. Note=A chromosomal aberration involving MAPK10 has been
CC       found in a single patient. Translocation t(Y;4)(q11.2;q21) which
CC       causes MAPK10 truncation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JNK3ID427.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07620; AAC50101.1; -; mRNA.
DR   EMBL; U34819; AAC50604.1; -; mRNA.
DR   EMBL; U34820; AAC50605.1; -; mRNA.
DR   EMBL; AC096953; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05963.1; -; Genomic_DNA.
DR   EMBL; BC035057; AAH35057.1; -; mRNA.
DR   IPI; IPI00003148; -.
DR   IPI; IPI00023547; -.
DR   PIR; S71104; S71104.
DR   RefSeq; NP_002744.1; -.
DR   RefSeq; NP_620446.1; -.
DR   RefSeq; NP_620448.1; -.
DR   UniGene; Hs.125503; -.
DR   UniGene; Hs.723352; -.
DR   PDB; 1JNK; X-ray; 2.30 A; A=1-423.
DR   PDB; 1PMN; X-ray; 2.20 A; A=40-401.
DR   PDB; 1PMQ; X-ray; 2.20 A; A=40-401.
DR   PDB; 1PMU; X-ray; 2.70 A; A=40-401.
DR   PDB; 1PMV; X-ray; 2.50 A; A=40-401.
DR   PDB; 2B1P; X-ray; 1.90 A; A=46-400.
DR   PDB; 2EXC; X-ray; 2.75 A; X=45-400.
DR   PDB; 2O0U; X-ray; 2.10 A; A=39-402.
DR   PDB; 2O2U; X-ray; 2.45 A; A=39-402.
DR   PDB; 2OK1; X-ray; 2.40 A; A=40-402.
DR   PDB; 2P33; X-ray; 2.40 A; A=40-402.
DR   PDB; 2R9S; X-ray; 2.40 A; A/B=46-401.
DR   PDB; 2WAJ; X-ray; 2.40 A; A=39-402.
DR   PDB; 2ZDT; X-ray; 2.00 A; A=39-402.
DR   PDB; 2ZDU; X-ray; 2.50 A; A=39-402.
DR   PDB; 3CGF; X-ray; 3.00 A; A=40-402.
DR   PDB; 3CGO; X-ray; 3.00 A; A=40-402.
DR   PDB; 3DA6; X-ray; 2.00 A; A=39-402.
DR   PDB; 3FI2; X-ray; 2.28 A; A=39-402.
DR   PDB; 3FI3; X-ray; 2.20 A; A=39-402.
DR   PDB; 3FV8; X-ray; 2.28 A; A=39-402.
DR   PDB; 3G90; X-ray; 2.40 A; X=40-402.
DR   PDB; 3G9L; X-ray; 2.20 A; X=40-402.
DR   PDB; 3G9N; X-ray; 2.80 A; A=40-402.
DR   PDB; 3KVX; X-ray; 2.40 A; A=39-402.
DR   PDBsum; 1JNK; -.
DR   PDBsum; 1PMN; -.
DR   PDBsum; 1PMQ; -.
DR   PDBsum; 1PMU; -.
DR   PDBsum; 1PMV; -.
DR   PDBsum; 2B1P; -.
DR   PDBsum; 2EXC; -.
DR   PDBsum; 2O0U; -.
DR   PDBsum; 2O2U; -.
DR   PDBsum; 2OK1; -.
DR   PDBsum; 2P33; -.
DR   PDBsum; 2R9S; -.
DR   PDBsum; 2WAJ; -.
DR   PDBsum; 2ZDT; -.
DR   PDBsum; 2ZDU; -.
DR   PDBsum; 3CGF; -.
DR   PDBsum; 3CGO; -.
DR   PDBsum; 3DA6; -.
DR   PDBsum; 3FI2; -.
DR   PDBsum; 3FI3; -.
DR   PDBsum; 3FV8; -.
DR   PDBsum; 3G90; -.
DR   PDBsum; 3G9L; -.
DR   PDBsum; 3G9N; -.
DR   PDBsum; 3KVX; -.
DR   ProteinModelPortal; P53779; -.
DR   DIP; DIP-1015N; -.
DR   IntAct; P53779; 7.
DR   MINT; MINT-1373516; -.
DR   STRING; P53779; -.
DR   PhosphoSite; P53779; -.
DR   PRIDE; P53779; -.
DR   Ensembl; ENST00000359221; ENSP00000352157; ENSG00000109339.
DR   Ensembl; ENST00000412000; ENSP00000398480; ENSG00000109339.
DR   GeneID; 5602; -.
DR   KEGG; hsa:5602; -.
DR   UCSC; uc003hpq.1; human.
DR   CTD; 5602; -.
DR   GeneCards; GC04M086878; -.
DR   HGNC; HGNC:6872; MAPK10.
DR   HPA; CAB022625; -.
DR   MIM; 602897; gene.
DR   MIM; 606369; phenotype.
DR   PharmGKB; PA30617; -.
DR   eggNOG; prNOG17099; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P53779; -.
DR   OMA; DEREHSI; -.
DR   PhylomeDB; P53779; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21762; -.
DR   ArrayExpress; P53779; -.
DR   Bgee; P53779; -.
DR   CleanEx; HS_MAPK10; -.
DR   Genevestigator; P53779; -.
DR   GermOnline; ENSG00000109339; Homo sapiens.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004705; F:JUN kinase activity; ISS:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   InterPro; IPR008351; JNK_MAPK.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Epilepsy; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    464       Mitogen-activated protein kinase 10.
FT                                /FTId=PRO_0000186277.
FT   DOMAIN       64    359       Protein kinase.
FT   NP_BIND      70     78       ATP.
FT   MOTIF       221    223       TXY.
FT   ACT_SITE    189    189       Proton acceptor.
FT   BINDING      93     93       ATP.
FT   MOD_RES     221    221       Phosphothreonine.
FT   MOD_RES     223    223       Phosphotyrosine.
FT   MOD_RES     415    415       Phosphoserine.
FT   MOD_RES     417    417       Phosphoserine.
FT   VAR_SEQ     418    464       GAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAG
FT                                PLGCCR -> AQVQQ (in isoform Alpha-1).
FT                                /FTId=VSP_004839.
FT   STRAND       47     53
FT   STRAND       56     61
FT   STRAND       64     72
FT   STRAND       74     83
FT   TURN         84     87
FT   STRAND       88     97
FT   HELIX        98    100
FT   HELIX       102    117
FT   STRAND      126    130
FT   TURN        136    138
FT   STRAND      141    147
FT   STRAND      150    152
FT   HELIX       153    157
FT   HELIX       163    182
FT   HELIX       192    194
FT   STRAND      195    197
FT   STRAND      203    205
FT   HELIX       232    235
FT   HELIX       244    258
FT   HELIX       268    279
FT   TURN        284    286
FT   HELIX       287    289
FT   HELIX       292    299
FT   HELIX       309    312
FT   HELIX       323    339
FT   TURN        344    346
FT   HELIX       350    354
FT   TURN        357    359
FT   HELIX       360    362
FT   HELIX       365    368
FT   HELIX       389    398
SQ   SEQUENCE   464 AA;  52585 MW;  2E20C05EB89CDA66 CRC64;
     MSLHFLYYCS EPTLDVKIAF CQGFDKQVDV SYIAKHYNMS KSKVDNQFYS VEVGDSTFTV
     LKRYQNLKPI GSGAQGIVCA AYDAVLDRNV AIKKLSRPFQ NQTHAKRAYR ELVLMKCVNH
     KNIISLLNVF TPQKTLEEFQ DVYLVMELMD ANLCQVIQME LDHERMSYLL YQMLCGIKHL
     HSAGIIHRDL KPSNIVVKSD CTLKILDFGL ARTAGTSFMM TPYVVTRYYR APEVILGMGY
     KENVDIWSVG CIMGEMVRHK ILFPGRDYID QWNKVIEQLG TPCPEFMKKL QPTVRNYVEN
     RPKYAGLTFP KLFPDSLFPA DSEHNKLKAS QARDLLSKML VIDPAKRISV DDALQHPYIN
     VWYDPAEVEA PPPQIYDKQL DEREHTIEEW KELIYKEVMN SEEKTKNGVV KGQPSPSGAA
     VNSSESLPPS SSVNDISSMS TDQTLASDTD SSLEASAGPL GCCR
//
